Literature DB >> 6202572

Diclofenac increases beta-endorphin plasma concentrations.

A Martini, G P Bondiolotti, P Sacerdote, L Pierro, G B Picotti, A E Panerai, L Restelli, F Zancaner, G Monza.   

Abstract

Plasma and ventricular cerebro-spinal fluid (CSF) Beta-endorphin concentrations were evaluated after chromatographic separation in patients carrying a ventricular shunt before and after the administration of diclofenac or placebo. In the same subjects the ventricular CSF concentrations of the serotonin and the catecholamine metabolites 5-hydroxyindole-acetic acid (5-HIAA), homovanillic acid (HVA) and MOPEG were also evaluated. Plasma, but not ventricular, Beta-endorphin concentrations increased significantly after diclofenac, while placebo was ineffective. No significant changes in ventricular 5-HIAA, HVA or MOPEG levels were observed. These data suggest a role for Beta-endorphin in the analgesic effect of diclofenac.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202572     DOI: 10.1177/030006058401200205

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  10 in total

Review 1.  Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.

Authors:  C Litalien; E Jacqz-Aigrain
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Central, naloxone-reversible antinociception by diclofenac in the rat.

Authors:  R Björkman; J Hedner; T Hedner; M Henning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

Review 3.  The mechanisms of action of NSAIDs in analgesia.

Authors:  J N Cashman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Piroxicam-induced analgesia: evidence for a central component which is not opioid mediated.

Authors:  A Fabbri; G Cruccu; P Sperti; M Ridolfi; T Ciampani; M G Leardi; S Ferracuti; V Bonifacio
Journal:  Experientia       Date:  1992-12-01

Review 5.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

6.  Reversal by naloxone of the spinal antinociceptive actions of a systemically-administered NSAID.

Authors:  J F Herrero; P M Headley
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 7.  The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects.

Authors:  K McCormack
Journal:  Drugs       Date:  1994       Impact factor: 9.546

8.  Long-term Morphine-treated Rats are more Sensitive to Antinociceptive Effect of Diclofenac than the Morphine-naive rats.

Authors:  Esmaeil Akbari; Ebrahim Mirzaei; Naghi Shahabi Majd
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 9.  A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Authors:  Fabiola Atzeni; Ignazio Francesco Masala; Piercarlo Sarzi-Puttini
Journal:  Pain Ther       Date:  2018-06-05

10.  Effects of topical flurbiprofen sodium, diclofenac sodium, ketorolac tromethamine and benzalkonium chloride on corneal sensitivity in normal dogs.

Authors:  Raquel de Araújo Cantarella; Juliana Kravetz de Oliveira; Daniel M Dorbandt; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2017-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.